Skip to Main Content

Paper Details

Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration.
Nat Immunol
125
2018
5B8, AD, Alzheimer's disease, Fibrin, MS, NADPH, amyloid, autoimmune and neurodegenerative diseases, fibrin, fibrin epitope, inflammation, monoclonal antibody 5B8, multiple sclerosis, neurodegeneration, neuroinflammation, neurological diseases, nicotinamide adenine dinucleotide phosphate, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, proinflammatory genes
Author NameAffiliation
Jae K RyuGladstone Institutes
Anke Meyer-FrankeGladstone Institutes
Kristina HanspersGladstone Institutes
Andrew S MendiolaGladstone Institutes
Hiroyuki HakozakiNational Center for Microscopy and Imaging Research, University of California
Hiroyuki HakozakiNational Center for Microscopy and Imaging Research, University of California
Mark H EllismanNational Center for Microscopy and Imaging Research, University of California
Mark H EllismanUniversity of California
Mark H EllismanNational Center for Microscopy and Imaging Research, University of California
Mark H EllismanUniversity of California
Scott S ZamvilUniversity of California san francisco
Alexander R PicoGladstone Institutes
Alexander R PicoGladstone Institutes
Lennart MuckeGladstone Institutes
Lennart MuckeUniversity of California san francisco
Katerina AkassoglouGladstone Institutes
Katerina AkassoglouUniversity of California
Katerina AkassoglouUniversity of California san francisco
  • 1 - 18

Datasets

Release 1.2